[Epidemiology of hematogenous infections due to Candida spp]
- PMID: 14576875
- DOI: 10.1590/s0037-86822003000500010
[Epidemiology of hematogenous infections due to Candida spp]
Abstract
Candida spp is associated to almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. Candida spp is the fourth most common cause of blood stream infections in the United States, where this agent is responsible for 8% of all invasive infections documented in this site. At the present, non-albicans species are related to at least 50% of all invasive infections due to Candida spp and they present differences in terms of clinical outcome as well as susceptibility to antifungal drugs. The crude mortality rate of candidemia is between 40 and 60% which makes this infection an important challenge for all clinicians from tertiary care hospitals of diverse different countries.
Similar articles
-
Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: a case-control study.Braz J Infect Dis. 2006 Feb;10(1):36-40. doi: 10.1590/s1413-86702006000100008. Epub 2006 Jun 2. Braz J Infect Dis. 2006. PMID: 16767314
-
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.Braz J Infect Dis. 2000 Jun;4(3):113-8. Braz J Infect Dis. 2000. PMID: 10934493 Review.
-
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital.Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):602-7. doi: 10.1007/s100960000325. Eur J Clin Microbiol Infect Dis. 2000. PMID: 11014622
-
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.Clin Microbiol Infect. 2006 Jan;12(1):75-80. doi: 10.1111/j.1469-0691.2005.01310.x. Clin Microbiol Infect. 2006. PMID: 16460550
-
The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy.Am J Health Syst Pharm. 1999 Mar 15;56(6):525-33; quiz 534-5. Am J Health Syst Pharm. 1999. PMID: 10192687 Review.
Cited by
-
Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.Mycopathologia. 2013 Apr;175(3-4):265-72. doi: 10.1007/s11046-013-9638-z. Epub 2013 Mar 27. Mycopathologia. 2013. PMID: 23532754
-
The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters.Mycopathologia. 2007 May;163(5):261-6. doi: 10.1007/s11046-007-9007-x. Epub 2007 Apr 11. Mycopathologia. 2007. PMID: 17436118
-
Candida albicans osteomyelitis as a cause of chest pain and visual loss.BMJ Case Rep. 2015 Oct 16;2015:bcr2015211327. doi: 10.1136/bcr-2015-211327. BMJ Case Rep. 2015. PMID: 26475877 Free PMC article.
-
Rondonin: antimicrobial properties and mechanism of action.FEBS Open Bio. 2021 Sep;11(9):2541-2559. doi: 10.1002/2211-5463.13253. Epub 2021 Aug 19. FEBS Open Bio. 2021. PMID: 34254458 Free PMC article.
-
Isoeugenol and Hybrid Acetamides against Candida albicans Isolated from the Oral Cavity.Pharmaceuticals (Basel). 2020 Oct 3;13(10):291. doi: 10.3390/ph13100291. Pharmaceuticals (Basel). 2020. PMID: 33023068 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous